Ablacon
Provider of AI-guided atrial fibrillation therapies.
Launch date
Employees
Market cap
-
Enterprise valuation
€109—164m (Dealroom.co estimates Jan 2021.)
Wheat Ridge Colorado (HQ)
Financials
Estimates*
| USD | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 1.4m | 2.3m | 2.9m | 2.9m | 2.9m |
| % growth | - | 62 % | 26 % | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $2.0m | Series A | |
| N/A | $30.0m | Series B | |
| Total Funding | €29.1m | ||
Related Content
Recent News about Ablacon
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.